[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-181126044--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-181126044","PRESSRELEASE"," Berlin Heals Initiates International Randomized, Double-Blind, Sham-Controlled C-MIC IV Trial","2026-11-18T11:07:25.000+01:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> \nNews provided by Berlin Heals Holding AG \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fwww.prnewswire.com\u002Fnews\u002Fberlin-heals-holding-ag\u002F\">\u003C\u002Fa>\u003C\u002Fp>\u003Cp> ZUG, Switzerland, Nov. 18, 2026 \u002FPRNewswire\u002F -- Berlin Heals Holding AG, a clinical-stage medical device company developing a first-in-class microcurrent therapy for heart failure, today announced the initiation of the international C-MIC IV trial and the first patient implantation. This new trial builds on the C-MIC III study, which introduced a less invasive implantation approach performed as an outpatient procedure in a cardiac catheterization laboratory. C-MIC IV marks the first evaluation of microcurrent therapy in a double-blind sham-controlled trial, with patients randomized 1:1 to active treatment or sham control.\u003C\u002Fp>\u003Cp> \n    \n                \n                    \n                \n    \nThe study will enroll 60 patients across six European countries: Spain, Belgium, Netherlands, Denmark, Serbia and Bosnia & Herzegovina. Participants will have symptomatic heart failure of either non-ischemic or ischemic etiology with a reduced ejection fraction above 20%. This represents a substantial broadening of the study population compared with previous studies. All patients will have devices implanted but will be blinded to whether therapy is on or off. With the completion of CMIC-IV, Berlin Heals will increase the clinical experience of microcurrent technology to over 120 heart failure patients.\u003C\u002Fp>\u003Cp> The first patient was implanted in Kragujevac, Serbia and treated by Dr. Miodrag Sreckovic, Head of Interventional Cardiology at the University Clinical Center Kragujevac.\u003C\u002Fp>\u003Cp> John Brumfield, CEO of Berlin Heals, said: \"Initiation of the international CMIC-IV trial marks a pivotal moment for Berlin Heals as we continue to build a robust body of evidence for this novel therapy. \"\u003C\u002Fp>\u003Cp> Dr Faouzi Kallel, Chief Scientific Officer of Berlin Heals, added \"CMIC-IV is the second randomized trial of microcurrent therapy, further characterizing safety and efficacy to inform the design of our planned pivotal IDE trial.\"\u003C\u002Fp>\u003Cp> \"Randomized, double-blind, sham-controlled trials can be challenging to conduct with implantable medical devices because of the difficulty of maintaining blinding\", said Global Principal Investigator Stefan Anker, Professor of Medicine Charite, \"because microcurrent therapy is not perceived by the patient and treatment allocation can be concealed from assessing clinicians, CMIC-IV allows us to evaluate the therapy using a rigorous, double-blind, sham-controlled design.\"\u003C\u002Fp>\u003Cp> Berlin Heals Holding AG is a Swiss joint-stock company founded in 2014. The company's C-MIC technology delivers a constant electrical microcurrent to the heart, generating a localized electrical field designed to improve cardiac function. Clinical findings to date suggest that this approach may provide early and sustained improvements in patients suffering from chronic heart failure.\u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp>  View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Fberlin-heals-initiates-international-randomized-double-blind-sham-controlled-c-mic-iv-trial-302943663.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","News provided by Berlin Heals Holding AG ZUG, Switzerland, Nov. 18, 2026 \u002FPRNewswire\u002F -- Berlin Heals Holding AG, a clinical-stage medical device company develo",[16,17,22,27,32,37,42,47,52,57],{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":18,"title":19,"pubDate":20,"logoUrl":8,"thirdParty":11,"orgId":13,"description":21},"CSN-181126042"," New global dataset maps where mining and metals intersect with biodiversity","2026-11-18T11:01:25.000+01:00","Risks and opportunities for biodiversity and business are unevenly distributed across a relatively small number of locations, according to the first analysis of",{"id":23,"title":24,"pubDate":25,"logoUrl":8,"thirdParty":11,"orgId":13,"description":26},"CSN-181126040"," RayNeo Finishes 2026 Strong with Black Friday Deals Across Its Smart Glasses Portfolio","2026-11-18T10:55:25.000+01:00","With more than one million cumulative shipments worldwide, RayNeo brings holiday savings to wearable gaming displays and everyday AI smart glasses. BERLIN, Nov.",{"id":28,"title":29,"pubDate":30,"logoUrl":8,"thirdParty":11,"orgId":13,"description":31},"CSN-181126035"," Indian Prime Minister Mr. Narendra Modi launches IIT Madras mission to create 3D atlases of 100+ Human Brains","2026-11-18T10:31:25.000+01:00","Sudha Gopalakrishnan Brain Centre at IIT Madras, India's No. 1-ranked engineering institute, aims to create the world's largest set of whole-human-brain 3D maps",{"id":33,"title":34,"pubDate":35,"logoUrl":8,"thirdParty":11,"orgId":13,"description":36},"CSN-181126030"," Human behaviour remains a critical blind spot in insider risk, new Signpost Six report warns","2026-11-18T10:01:24.000+01:00","THE HAGUE, Netherlands, Nov. 18, 2026 \u002FPRNewswire\u002F -- European organisations, particularly those in defence, critical infrastructure, and transport and logistic",{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-181126022"," Voltage Energy Unveils Microgrid System and New EBOS Solutions at RE+ 2026","2026-11-18T08:46:25.000+01:00","New offerings support rapid deployment and better energy economics for mission-critical power while improving installation efficiency and project flexibility in",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-181126018"," Anycubic Showcases Thingiverse Partnership Progress and AnyLab AI Creation Tool at Formnext 2026","2026-11-18T08:27:25.000+01:00","FRANKFURT, Germany, Nov. 18, 2026 \u002FPRNewswire\u002F -- Anycubic, a consumer 3D printing brand, is exhibiting at Formnext 2026 in Frankfurt, Germany, at Booth F01 in ",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-181126013"," CJ BIO to Showcase Next-Generation Taste & Nutrition Innovations at Fi Europe 2026, Unveiling TasteNrich® Harmony KOKU","2026-11-18T07:31:25.000+01:00","Under the banner \"More of what you want, less of what you don't,\" CJ BIO introduces clean-label solutions delivering profound mouthfulness and lasting savory de",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-181126001"," ELEGOO Showcases New Solutions Across Resin Printing, FDM Printing and 3D Scanning at Formnext 2026","2026-11-18T00:14:25.000+01:00","FRANKFURT, Germany, Nov. 17, 2026 \u002FPRNewswire\u002F -- ELEGOO, a rapidly developing brand in the global smart manufacturing industry, kicked off its participation at",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-171126208"," Clapp Finance lanceert Corporate Crypto Credit Lines: cryptoleningen voor bedrijven vanaf 1% JKP","2026-11-17T20:47:25.000+01:00","PRAAG, 17 november 2026 \u002FPRNewswire\u002F -- Clapp Finance heeft vandaag Corporate Crypto Credit Lines aangekondigd, een nieuwe manier voor bedrijven om werkkapitaal"]